JP2012500636A - 固体含有生物抽出物のウイルスおよび微生物含有量を低減する方法 - Google Patents

固体含有生物抽出物のウイルスおよび微生物含有量を低減する方法 Download PDF

Info

Publication number
JP2012500636A
JP2012500636A JP2011524251A JP2011524251A JP2012500636A JP 2012500636 A JP2012500636 A JP 2012500636A JP 2011524251 A JP2011524251 A JP 2011524251A JP 2011524251 A JP2011524251 A JP 2011524251A JP 2012500636 A JP2012500636 A JP 2012500636A
Authority
JP
Japan
Prior art keywords
solid
extract
containing biological
pressure treatment
biological extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011524251A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012500636A5 (https=
Inventor
レムシュ・クリスティアン
シュレーダー・トーマス
メースト・トーマス
クーアフュルスト・マンフレート
Original Assignee
ノルドマルク・アルツナイミッテル・ゲゼルシヤフト・ミト・ベシュレンクテル・ハフツング・ウント・コンパニー・コマンデイトゲゼルシヤフト
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41110856&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP2012500636(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by ノルドマルク・アルツナイミッテル・ゲゼルシヤフト・ミト・ベシュレンクテル・ハフツング・ウント・コンパニー・コマンデイトゲゼルシヤフト filed Critical ノルドマルク・アルツナイミッテル・ゲゼルシヤフト・ミト・ベシュレンクテル・ハフツング・ウント・コンパニー・コマンデイトゲゼルシヤフト
Publication of JP2012500636A publication Critical patent/JP2012500636A/ja
Publication of JP2012500636A5 publication Critical patent/JP2012500636A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/94—Pancreatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
JP2011524251A 2008-08-27 2009-08-27 固体含有生物抽出物のウイルスおよび微生物含有量を低減する方法 Pending JP2012500636A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DE102008039860 2008-08-27
DE102008039860.8 2008-08-27
EP09007797.5 2009-06-12
EP09007797A EP2165717A1 (de) 2008-08-27 2009-06-12 Verfahren zur Verringerung der viralen und mikrobiellen Belastung feststoffhaltiger biologischer Extrakte
PCT/EP2009/004318 WO2010022808A1 (de) 2008-08-27 2009-06-16 Verfahren zur verringerung der viralen und mikrobiellen belastung feststoffhaltiger biologischer extrakte
EPPCT/EP2009/004318 2009-06-16
PCT/EP2009/006216 WO2010022946A1 (de) 2008-08-27 2009-08-27 Verfahren zur verringerung der viralen und mikrobiellen belastung feststoffhaltiger biologischer extrakte

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015124437A Division JP6109881B2 (ja) 2008-08-27 2015-06-22 固体含有生物抽出物のウイルスおよび微生物含有量を低減する方法

Publications (2)

Publication Number Publication Date
JP2012500636A true JP2012500636A (ja) 2012-01-12
JP2012500636A5 JP2012500636A5 (https=) 2012-08-16

Family

ID=41110856

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011524251A Pending JP2012500636A (ja) 2008-08-27 2009-08-27 固体含有生物抽出物のウイルスおよび微生物含有量を低減する方法
JP2015124437A Expired - Fee Related JP6109881B2 (ja) 2008-08-27 2015-06-22 固体含有生物抽出物のウイルスおよび微生物含有量を低減する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015124437A Expired - Fee Related JP6109881B2 (ja) 2008-08-27 2015-06-22 固体含有生物抽出物のウイルスおよび微生物含有量を低減する方法

Country Status (7)

Country Link
US (1) US9107966B2 (https=)
EP (2) EP2165717A1 (https=)
JP (2) JP2012500636A (https=)
BR (1) BRPI0917840B1 (https=)
ES (1) ES2532637T3 (https=)
PL (1) PL2328623T3 (https=)
WO (2) WO2010022808A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2165717A1 (de) 2008-08-27 2010-03-24 Nordmark Arzneimittel GmbH & Co.KG Verfahren zur Verringerung der viralen und mikrobiellen Belastung feststoffhaltiger biologischer Extrakte
ES2488407T3 (es) 2009-01-29 2014-08-27 Nordmark Arzneimittel Gmbh & Co. Kg Preparación farmacéutica que contiene lipasa de origen bacteriano
PL2295039T5 (pl) * 2009-08-28 2023-02-27 Nordmark Pharma Gmbh Sposób wytwarzania granulek zawierających pankreatynę, w szczególności mikrogranulek zawierających pankreatynę, oraz wytworzone tym sposobem granulki zawierające pankreatynę
EP2489349B1 (de) 2011-02-17 2014-05-28 Nordmark Arzneimittel GmbH & Co.KG Pankreatin-Pellets, insbesondere Pankreatin-Mikropellets, und Verfahren zu deren Herstellung
MX380367B (es) 2015-05-19 2025-03-12 Scient Protein Laboratories Llc Metodo para reducir o inactivar contenido viral o microbiano en los procesos para la fabricacion de pancreatina.
DE102015119006A1 (de) 2015-11-05 2017-05-11 Nordmark Arzneimittel Gmbh & Co. Kg Verfahren zur Reduzierung der Belastung von Pankreatin mit Mikroorganismen
CN108795920B (zh) * 2018-06-22 2022-04-08 苏州良辰生物医药科技有限公司 一种胰酶的制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4623624A (en) * 1982-12-30 1986-11-18 Basf Aktiengesellschaft Isolation of pancreatin
WO2002056824A2 (en) * 2000-08-10 2002-07-25 Boston Biomedica, Inc. Pressure cycling inactivation of pathogens in biological materials used for therapeutics or vaccines
WO2007014896A1 (en) * 2005-07-29 2007-02-08 Solvay Pharmaceuticals Gmbh Processes for the manufacture of sterilized pancreatin powder

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA394981A (en) * 1941-03-04 The Griffith Laboratories Pancreatin sterilization
US2189948A (en) * 1938-10-31 1940-02-13 Griffith Laboratories Sterilization of pancreatin
US3493399A (en) 1967-04-11 1970-02-03 Ezra Levin Pancreatic food product
DE2923279C2 (de) 1979-06-08 1987-07-09 Kali-Chemie Pharma Gmbh, 3000 Hannover Verfahren zur Herstellung von Pankreatin-Pellets und diese enthaltende Arzneimittel
DE3248588A1 (de) 1982-12-30 1984-07-12 Nordmark-Werke Gmbh, 2000 Hamburg Verfahren zur gewinnung von pankreatin von hohem schuettgewicht
CA2030581C (en) 1989-11-24 2000-06-27 Gunther Atzl Pancreatin preparations
DE4227385A1 (de) 1992-08-19 1994-02-24 Kali Chemie Pharma Gmbh Pankreatinmikropellets
US6696019B2 (en) † 1998-06-15 2004-02-24 Bbi Bioseq, Inc. Rapid cryobaric sterilization and vaccine preparation
US6270723B1 (en) * 1998-06-15 2001-08-07 Bbi Bioseq, Inc. Rapid cryobaric sterilization and vaccine preparation
FR2804326B1 (fr) * 2000-01-27 2002-10-18 Ellipse Pharmaceuticals Procede de sterilisation par traitement sous hautes pressions de principes actifs sensibles
CA2560613C (en) 2004-03-22 2015-11-24 Solvay Pharmaceuticals Gmbh Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants
WO2006044529A1 (en) 2004-10-14 2006-04-27 Altus Pharmaceuticals Inc. Compositions containing lipase; protease and amylase for treating pancreatic insufficiency
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
WO2008127567A1 (en) 2007-04-13 2008-10-23 Beth Israel Deaconess Medical Center, Inc. Novel nutritional food products for improved digestion and intestinal absorption
EP2165717A1 (de) 2008-08-27 2010-03-24 Nordmark Arzneimittel GmbH & Co.KG Verfahren zur Verringerung der viralen und mikrobiellen Belastung feststoffhaltiger biologischer Extrakte
ES2488407T3 (es) 2009-01-29 2014-08-27 Nordmark Arzneimittel Gmbh & Co. Kg Preparación farmacéutica que contiene lipasa de origen bacteriano
PL2295039T5 (pl) 2009-08-28 2023-02-27 Nordmark Pharma Gmbh Sposób wytwarzania granulek zawierających pankreatynę, w szczególności mikrogranulek zawierających pankreatynę, oraz wytworzone tym sposobem granulki zawierające pankreatynę
EP2489349B1 (de) 2011-02-17 2014-05-28 Nordmark Arzneimittel GmbH & Co.KG Pankreatin-Pellets, insbesondere Pankreatin-Mikropellets, und Verfahren zu deren Herstellung

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4623624A (en) * 1982-12-30 1986-11-18 Basf Aktiengesellschaft Isolation of pancreatin
WO2002056824A2 (en) * 2000-08-10 2002-07-25 Boston Biomedica, Inc. Pressure cycling inactivation of pathogens in biological materials used for therapeutics or vaccines
WO2007014896A1 (en) * 2005-07-29 2007-02-08 Solvay Pharmaceuticals Gmbh Processes for the manufacture of sterilized pancreatin powder

Also Published As

Publication number Publication date
WO2010022808A1 (de) 2010-03-04
JP6109881B2 (ja) 2017-04-05
EP2328623B1 (de) 2014-12-24
JP2015198670A (ja) 2015-11-12
US9107966B2 (en) 2015-08-18
WO2010022946A1 (de) 2010-03-04
PL2328623T3 (pl) 2015-08-31
US20110268844A1 (en) 2011-11-03
BRPI0917840B1 (pt) 2018-08-14
EP2328623A1 (de) 2011-06-08
ES2532637T3 (es) 2015-03-30
EP2328623B2 (de) 2024-04-03
EP2165717A1 (de) 2010-03-24
BRPI0917840A2 (pt) 2015-08-11

Similar Documents

Publication Publication Date Title
JP6109881B2 (ja) 固体含有生物抽出物のウイルスおよび微生物含有量を低減する方法
US8283147B2 (en) Pancreatin and method for reducing the viral and microbial contamination of pancreatin
RU2413532C2 (ru) Способ получения стерилизованного порошкообразного панкреатина
KR102671387B1 (ko) 혈소판 용해질을 멸균시키기 위한 방법
US10184121B2 (en) Methods for removing viral contaminants from pancreatic extracts
JPH0660105B2 (ja) 血漿中の肝炎ウイルスの不活性化方法
JP2016527247A5 (https=)
JP2012500636A5 (https=)
CN101613394A (zh) 鼠神经生长因子的制备方法和注射用鼠神经生长因子的制备方法
CN107849552B (zh) 在生产胰液素过程中减少或灭活病毒和微生物内容物的方法
KR101798386B1 (ko) 카프릴레이트 바이러스 불활성화
US20100119654A1 (en) Method for reducing the virus and micro-organism content of biological extracts which contain solids and extract produced according to the method
JPS59130819A (ja) 血しようタンパク製品の溶媒処理法
US9676817B2 (en) Method for the removal of virus from a protein solution
CN1302009C (zh) 用有机溶剂病毒灭活法制备鼠神经生长因子的工艺
CN102210854A (zh) 猪纤维蛋白原冻干加热病毒灭活的方法
JP2002037740A (ja) 発酵組成物、並びに該発酵組成物を含有する抗アレルギー性組成物及び抗酸化性組成物
Schmidt et al. Inhibitors of Echovirus and Reovirus Hemagglutination: I. Inhibitors in Tissue Culture Fluids
US2432970A (en) Method of reducing the pyrogen contents of parenteral solutions
CN118064419A (zh) 一种去除病毒制备胰酶的方法
CN111630164A (zh) 具有减少的病毒和微生物污染的酶组合物
Cai et al. Enhanced RT-qPCR detection of norovirus in fresh salads using a novel bentonite-and starch-coated activated carbon concentration method
JP2008154456A (ja) タンパク質分解酵素
CN110885814A (zh) 一种在制备饲料级胰酶中的灭活病毒的方法
HK40059265A (en) Method for reducing or inactivating viral and microbial content in the processes for the manufacture of pancreatin

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120702

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120702

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140218

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140421

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140428

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140609

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140616

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140715

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140723

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140814

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150225